Detalles de la búsqueda
1.
The Glasgow Prognostic Score Predicts Survival Outcomes in Patients with Extensive-Stage Small Cell Lung Cancer.
Oncology
; 101(11): 695-704, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37494886
2.
The Glasgow Prognostic Score Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations Who Are Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors.
Oncology
; 101(11): 685-694, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37166346
3.
Real-world evaluation of second line chemotherapy for patients with advanced non-small cell lung cancer harboring preexisting interstitial lung disease.
Invest New Drugs
; 40(1): 182-189, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34415485
4.
Real-world assessment of afatinib for patients with EGFR-positive non-small cell lung cancer.
Invest New Drugs
; 38(6): 1906-1914, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32415486
5.
Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors.
Invest New Drugs
; 38(3): 885-893, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32157598
6.
Phase I study of Nedaplatin, a platinum based antineoplastic drug, combined with nab-paclitaxel in patients with advanced squamous non-small cell lung cancer.
Invest New Drugs
; 36(1): 45-52, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-28466376
7.
Efficacy of Platinum-Based Chemotherapy for Relapsed Small-Cell Lung Cancer after Amrubicin Monotherapy in Elderly Patients and Patients with Poor Performance Status.
Oncology
; 94(4): 207-214, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29393275
8.
Smoking History as a Predictor of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small Cell Lung Cancer Harboring EGFR Mutations.
Oncology
; 95(2): 109-115, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29698957
9.
Phase II study of Amrubicin monotherapy in elderly or poor-risk patients with extensive disease of small cell lung cancer.
Invest New Drugs
; 35(5): 642-648, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28631097
10.
[Pemetrexed as second-line treatment and beyond for elderly patients with advanced non-small-cell lung cancer].
Gan To Kagaku Ryoho
; 39(1): 59-62, 2012 Jan.
Artículo
en Japonés
| MEDLINE | ID: mdl-22241352
11.
A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer.
Cancer Manag Res
; 13: 8695-8705, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34849025
12.
Implementation of clinical sequencing for molecular profiling in patients with advanced cancer.
Cancer Biomark
; 31(2): 119-126, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33896820
13.
Amrubicin for treating elderly and poor-risk patients with small-cell lung cancer.
Int J Clin Oncol
; 15(5): 447-52, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20464623
14.
Synchronization between cardiac and respiratory rhythms in healthy subjects and patients.
Adv Exp Med Biol
; 662: 133-40, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20204783
15.
Current status and progress of concurrent chemoradiotherapy in patients with locally advanced non-small cell lung cancer prior to the approval of durvalumab.
Thorac Cancer
; 11(4): 1005-1014, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32057187
16.
Impact of Amrubicin Monotherapy as Second-Line Chemotherapy on Outcomes in Elderly Patients with Relapsed Extensive-Disease Small-Cell Lung Cancer.
Cancer Manag Res
; 12: 4911-4921, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32606979
17.
Effect of gefitinib on warfarin antithrombotic activity.
Int J Clin Oncol
; 14(4): 332-6, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19705244
18.
Activity of Nivolumab and Utility of Neutrophil-to-Lymphocyte Ratio as a Predictive Biomarker for Advanced Non-Small-Cell Lung Cancer: A Prospective Observational Study.
Clin Lung Cancer
; 20(3): 208-214.e2, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29803573
19.
Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer.
PLoS One
; 14(4): e0214599, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31002722
20.
Questionnaire survey on patient awareness of invasive rebiopsy in advanced non-small cell lung cancer.
Thorac Cancer
; 10(3): 501-507, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30648806